Citius Pharmaceuticals Inc. appointed drug industry veteran Kelly Creighton as executive vice president of chemistry, manufacturing and controls, the company announced Nov. 5. Creighton will be ...

-- FDA Chemistry, Manufacturing, and Controls (CMC) Development and Readiness Pilot (CDRP) program supports manufacturing readiness for therapies with expedited clinical development timelines -- ...

Better catalysts, solar-powered chemistry, and liquid modeling help chemical manufacturers cut emissions, reduce energy use, ...

Dublin, April 14, 2026 (GLOBE NEWSWIRE)-- The "Digital CMC: The Key To Realising Pharma 4.0 (June 23, 2026)" training has been added to ResearchAndMarkets.com's offering. The pharmaceutical and ...

Developing innovative pharmaceutical drugs and technologies is a complicated process. A robust chemistry, manufacturing, and controls (CMC) strategy is critical to determining a new drug’s success or ...

SAN DIEGO--(BUSINESS WIRE)--Janux Therapeutics, a biopharmaceutical company developing novel T cell engager immunotherapies, today announced the appointment of Charles Winter as Senior Vice President ...

Chemistry, Manufacturing and Controls (CMC): are all stages of the drug development life cycle, after drug discovery. During preclinical drug development, the proper analytical methods are validated ...

Drug Development needs innovation, creativity, and a multiple disciplinary method in gaining a successful path to approval. A successful program can offer a valuable opportunity for a drug development ...

Chemistry engineered for real-world solutions. The I&EC Division brings together the full spectrum of industrial chemistry and engineering to solve today’s most pressing technological challenges.

Peptides, as essential biomolecules linking amino acids and proteins, play a vital role across numerous disciplines, including life science research, drug discovery, biomaterials engineering, and ...

According to reports that continue to appear in trade publications, combined cycle power generation will, for some time, remain an important bridge technology between declining coal-fired power and ...

Wugen, Inc., a clinical-stage biotechnology company developing allogeneic, off-the-shelf cell therapies for the treatment of hematological malignancies, today announced that the U.S. Food and Drug ...